Clinical trial Recruiting at 1 site Phase1; Phase2 Interventional Ages 18 to 65

Vasopressin and Observational Analgesia in Healthy Volunteers

Official title: The Influence of Vasopressin on Observational Learning of Placebo Analgesia

Run by University of Maryland, Baltimore · NCT03446456 · Data updated 2026-11-12

We are testing whether intranasal vasopressin changes how people’s pain is shaped by watching others experience pain while in an MRI scan.

More Acute Pain trials

Quick facts

PhasePhase1; Phase2
Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment56 (estimated)
SponsorUniversity of Maryland, Baltimore
Academic / other
Locations1 site (Baltimore, Maryland)
StatusRecruiting · results posted
StartedSeptember 17, 2018
Main results expectedDecember 31, 2026
Study endsDecember 31, 2027
Registry record updatedOctober 28, 2026
Trial IDNCT03446456 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Healthy adults aged 18–55 who are English speakers without significant medical or psychiatric conditions.

Probably not a fit

Individuals with the listed exclusion criteria or those not experiencing pain may not derive any analgesic benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study explores how the hormone vasopressin might alter brain responses to pain when people watch others receive analgesia. It uses an interventional design with random assignment to vasopressin or saline, and a blinded setup for participants and researchers. The procedure includes an observational phase followed by a pain-testing phase in an fMRI environment to measure neural activity related to pain and social processing. The primary aim is to see if vasopressin enhances brain regions involved in social cognition during observational analgesia. The trial uses healthy adults aged 18–55 and excludes individuals with major health, psychiatric, or sensory risk factors.

Why it matters

Potential benefit: If successful, the approach could improve understanding of how vasopressin modulates socially influenced pain experiences and inform future analgesic strategies.

How similar studies have gone: This area combines genetics, neurochemistry, and social learning; prior work suggests social influence can modulate pain, but the specific role of vasopressin in observational analgesia is exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ( 18-55 years old)
* English speaker (written and spoken)

Exclusion Criteria:

* Cardiovascular, neurological diseases, pulmonary abnormalities, kidney disease, liver disease, degenerative neuromuscular disease, history of cancer within past 3 years
* Any history of chronic pain disorder or currently in pain
* Severe psychiatric condition (e.g. schizophrenia, bipolar disorders, mania, autism) and /or psychiatric condition leading to treatment and/or hospitalization within the last 3 years.
* Family (first degree) history of mania, schizophrenia, or other psychoses
* Lifetime alcohol/drug dependence or alcohol/drug abuse in past 3 months
* Pregnancy or breast feeding
* Color-blindness
* Impaired, uncorrected hearing
* History of angioedema
* High blood pressure (above 140 mmHg) or symptomatic low blood pressure
* History of fainting
* Left handed
* Allergies or sensitivities to creams, lotions or food coloring
* Any non-organic implant or any non-removable metal device (e.g. pacemaker, cochlear implants, stents, surgical clips, non-removable piercings)
* Any prior eye injury or the potential of a foreign body in the eye (e.g. worked in metal fields)Persisting functional impairment due to a head trauma
* Fear of closed spaces
* Any other contraindications for MRI (e.g. large tattoos on head and neck)
* Previously participated in a "Pain Perception in the Brain" Study
* Failed drug test (testing for opiates, cocaine, methamphetamines, amphetamines and THC)

Where it's running

  • Luana Colloca
    Baltimore, Maryland, United States
    Recruiting

Study contacts

  • Principal investigator: Luana Colloca, MD/PHD/MS — University of Maryland Baltimore School of Nursing
  • Study coordinator: Research Coordinator
  • Email: nrscollocalab@umaryland.edu
  • Phone: 410-706-5975

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.